Results 11 to 20 of about 125,774 (256)

Pharmacotherapy of resistant arterial hypertension [PDF]

open access: yesТерапевтический архив, 2018
Pharmacotherapy of resistant arterial hypertension represents a serious problem, because today there are no clear algorithms of action in this clinical situation. The review discusses the key works in which the authors propose a solution to this problem.
N E Shepeleva, A V Rodionov, V V Fomin
doaj   +3 more sources

Treatment-Resistant Hypertension in Individuals of High BMI

open access: yesPakistan Armed Forces Medical Journal, 2023
Objective: To determine the frequency of treatment-resistant hypertension in individuals of high BMI and factors associated with resistant hypertension Study Design: Comparative cross-sectional study Place and Duration of Study: Pak Emirates ...
Mohammad Zeeshan Akram   +5 more
doaj   +1 more source

A General Practice-based Approach to the Management of Resistant Hypertension First Diagnosed in the Community [PDF]

open access: yesZhongguo quanke yixue, 2022
Hypertension is one major chronic disease that threatens the health of Chinese people. Resistant hypertension is a special type of hypertension with complex pathogenesis and etiology, which is more harmful since it can increase the probability of ...
Yang CHEN, Xueping DU
doaj   +1 more source

Muscling in on Resistant Hypertension [PDF]

open access: yesCirculation, 2020
Sin financiación ; 29.690 JCR (2020) Q1, 3/142 Cardiac & Cardiovascular Systems ; 7.795 SJR (2020) Q1, 2/349 Cardiology and Cardiovascular Medicine ; No data IDR 2019 ...
Valenzuela Ruiz, Pedro Luis   +2 more
openaire   +3 more sources

Resistant hypertension [PDF]

open access: yesCanadian Journal of Cardiology, 2009
Resistant hypertension is most often due to insufficient medical therapy. With a patient history, physical examination and focused laboratory tests, sufficient information can be gathered to lead to further directed medical therapy, which most often includes a diuretic as part of the drug regimen.
Sheldon W, Tobe, Richard, Lewanczuk
openaire   +2 more sources

RESISTANT ARTERIAL HYPERTENSION

open access: yesЕвразийский Кардиологический Журнал, 2018
Resistant hypertension is defined as a lack to lower 140 mmHg (systolic blood pressure) and 90 mmHg (diastolic blood pressure) values of ambulatory blood pressure (BP) response using 3 antihypertensive agents of different classes, one of which should be ...
T. E. Esaulova   +3 more
doaj   +1 more source

What is resistant arterial hypertension?

open access: yesBlood Pressure, 2023
Purpose The current review is to describe the definition and prevalence of resistant arterial hypertension (RAH), the difference between refractory hypertension, patient characteristics and major risk factors for RAH, how RAH is diagnosed, prognosis and ...
Evgeniya V. Shalaeva, Franz H. Messerli
doaj   +1 more source

Rethinking Resistant Hypertension [PDF]

open access: yesJournal of Clinical Medicine, 2022
Resistant hypertension is common and known to be a risk factor for cardiovascular events, including stroke, myocardial infarction, heart failure, and cardiovascular mortality, as well as adverse renal events, including chronic kidney disease and end-stage kidney disease.
Gabrielle Bourque, Swapnil Hiremath
openaire   +2 more sources

Resistant Hypertension and Chronotherapy [PDF]

open access: yesMateria Socio Medica, 2015
Resistant hypertension is defined as blood pressure that remains above 140/90 mmHg in spite of the continuous use of three antihypertensive agents in optimal dose, including diuretic, and lifestyle changes. According to data from United States of America and Europe, the prevalence ranges from 10 up to 30% in patients with hypertension.
Prkačin, Ingrid   +5 more
openaire   +4 more sources

Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory

open access: yesSAGE Open Medicine, 2021
Background: Hypertension affects about 36 million Brazilians. It is estimated that 10%–20% of these have resistant hypertension. These patients are at an increased risk of early target organ damage, as well as cardiovascular and renal events.
Ana Flávia Moura   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy